Stock CSTL CASTLE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Castle Biosciences, Inc.

Equities

CSTL

US14843C1053

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
23.26 USD -3.92% Intraday chart for Castle Biosciences, Inc. -4.55% +7.78%
May. 30 Castle Biosciences, Inc. Announces to Present New Data Related to Its DecisionDx-Melanoma and DecisionDx-UM Tests At the 2024 American Society of Clinical Oncology CI
May. 29 Castle Biosciences, Inc. Announces That New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CSTL Stock
  4. Revisions Castle Biosciences, Inc.